Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM5A | P29375 | 3/20 | 0.43 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.43 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.43 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.43 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.40 |
| ▸ | PPARG | P37231 | 7/20 | 0.40 |
| ▸ | PPARD | Q03181 | 7/20 | 0.40 |
| ▸ | PPARA | Q07869 | 7/20 | 0.40 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.40 |
| ▸ | TLR2 | O60603 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | FABP4 | P15090 | 2/20 | 0.40 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.40 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1961006 | 1.00 | KDM5A (0.43) | KDM5APHF8KDM4CPAOXAKR1B1 | |
| SCHEMBL1274484 | 0.98 | KDM5A (0.44) | KDM5APHF8KDM4CPAOXAKR1B1 | |
| SCHEMBL28609397 | 0.97 | KDM5A (0.47) | KDM5APHF8KDM4CPAOXTSHR | |
| Acetic Acid SCHEMBL28942593 | 0.95 | PAOX (0.45) | KDM5APHF8KDM4CPAOXAKR1B1 | |
| SCHEMBL29986920 | 0.91 | EPHX2 (0.52) | PPARGPPARDPPARAPTPN1TDP1 | |
| Trolamine SCHEMBL28088316 | 0.89 | KDM5A (0.48) | KDM5APHF8KDM4CPAOXTSHR | |
| Trolamine SCHEMBL1962252 | 0.89 | KDM5A (0.48) | KDM5APHF8KDM4CPAOXTSHR | |
| SCHEMBL21981245 | 0.88 | EPHX2 (0.52) | PPARGPPARDPPARAPTPN1TDP1 | |
| SCHEMBL4945383 | 0.86 | TSHR (0.42) | KDM5APHF8KDM4CPAOXAKR1B1 | |
| Trolamine SCHEMBL27897006 | 0.85 | KDM5A (0.43) | KDM5APHF8KDM4CAKR1B1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1928402-B1 | Carnitine derivative, salt thereof, external skin preparation and cosmetic preparation | SHOWA DENKO KK (JP) | 2014-03-12 | — | — | EP | disclosed |
| US-8551509-B2 | Skin agent for external use and cosmetic agent including ubiquinone derivative or salt thereof and method using the same | SHOWA DENKO K.K. (JP) | 2013-10-08 | — | — | US | disclosed |
| US-20110144062-A1 | DERMATOLOGICAL ANTI-WRINKLE AGENT | SHOWA DENKO K.K. (JP) | 2011-06-16 | — | — | US | disclosed |
| US-7842726-B2 | Carnitine derivative, salt thereof, external skin preparation and cosmetic material | SHOWA DENKO K.K. (JP) | 2010-11-30 | — | — | US | disclosed |
| EP-1912708-B1 | EMULSIFIED SKIN EXTERNAL PREPARATION AND METHOD FOR STABILIZING THE SKIN EXTERNAL PREPARATION | SHOWA DENKO KK (JP) | 2010-09-08 | — | — | EP | disclosed |
| US-20100152134-A1 | EMULSIFIED SKIN EXTERNAL PREPARATION AND METHOD FOR STABILIZING THE SKIN EXTERNAL PREPARATION | SHOWA DENKO K.K. (JP) | 2010-06-17 | — | — | US | disclosed |
| US-20100074879-A1 | SKIN AGENT FOR EXTERNAL USE AND COSMETIC AGENT INCLUDING UBIQUINONE DERIVATIVE OR SALT THEREOF AND METHOD USING THE SAME | SHOWA DENKO K.K. (JP) | 2010-03-25 | — | — | US | disclosed |
| US-20090240070-A1 | WHITENING DERMATOLOGICAL PREPARATIONS | SHOWA DENKO K.K. (JP) | 2009-09-24 | — | — | US | disclosed |
| US-20090234153-A1 | CARNITINE DERIVATIVE, SALT THEREOF, EXTERNAL SKIN PREPARATION AND COSMETIC MATERIAL | SHOWA DENKO K.K. (JP) | 2009-09-17 | — | — | US | disclosed |
| US-20090203649-A1 | DERMATOLOGICAL ANTI-WRINKLE AGENT | SHOWA DENKO K.K. (JP) | 2009-08-13 | — | — | US | disclosed |
| EP-2081544-A1 | SKIN AGENT FOR EXTERNAL USE AND COSMETIC AGENT INCLUDING UBIQUINONE DERIVATIVE OR SALT THEREOF AND METHOD USING THE SAME | Showa Denko K.K. (JP) | 2009-07-29 | — | — | EP | disclosed |
| EP-2037873-A2 | DERMATOLOGICAL ANTI-WRINKLE AGENT | Showa Denko K.K. (JP) | 2009-03-25 | — | — | EP | disclosed |
| EP-1981492-A1 | WHITENING DERMATOLOGICAL PREPARATIONS | Showa Denko K.K. (JP) | 2008-10-22 | — | — | EP | disclosed |
| WO-2008047882-A1 | SKIN AGENT FOR EXTERNAL USE AND COSMETIC AGENT INCLUDING UBIQUINONE DERIVATIVE OR SALT THEREOF AND METHOD USING THE SAME | SHOWA DENKO K.K. (JP) | 2008-04-24 | — | — | WO | disclosed |
| EP-1909917-A1 | EMULSIFIED SKIN EXTERNAL PREPARATION AND METHOD FOR STABILIZING THE SKIN EXTERNAL PREPARATION | Showa Denko K.K. (JP) | 2008-04-16 | — | — | EP | disclosed |
| WO-2008001921-A2 | DERMATOLOGICAL ANTI-WRINKLE AGENT | SHOWA DENKO K.K. (JP) | 2008-01-03 | — | — | WO | disclosed |
| WO-2007091694-A1 | WHITENING DERMATOLOGICAL PREPARATIONS | SHOWA DENKO K.K. (JP) | 2007-08-16 | — | — | WO | disclosed |
| WO-2007043339-A9 | CARNITINE DERIVATIVE, SALT THEREOF, EXTERNAL SKIN PREPARATION AND COSMETIC MATERIAL | SHOWA DENKO KK (JP) | 2007-06-07 | — | — | WO | disclosed |
| WO-2007013633-A1 | EMULSIFIED SKIN EXTERNAL PREPARATION AND METHOD FOR STABILIZING THE SKIN EXTERNAL PREPARATION | SHOWA DENKO K.K. (JP) | 2007-02-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152134-A1 | EMULSIFIED SKIN EXTERNAL PREPARATION AND METHOD FOR STABILIZING THE SKIN EXTERNAL PREPARATION | DEGS1, DSG1, TTPA | KDM5A 3051/4885PHF8 1464/4885KDM4C 2601/4885 |
| US-20090203649-A1 | DERMATOLOGICAL ANTI-WRINKLE AGENT | CUTA, GLA, COL1A1 | KDM5A 777/4885PHF8 61/4885KDM4C 1272/4885 |
| US-20110144062-A1 | DERMATOLOGICAL ANTI-WRINKLE AGENT | CUTA, COL1A1, GLA | KDM5A 703/4885PHF8 58/4885KDM4C 1246/4885 |
| US-20100074879-A1 | SKIN AGENT FOR EXTERNAL USE AND COSMETIC AGENT INCLUDING UBIQUINONE DERIVATIVE OR SALT THEREOF AND METHOD USING THE SAME | NDUFA11, NDUFA12, NDUFA1 | KDM5A 2390/4885PHF8 851/4885KDM4C 2933/4885 |
| US-20090234153-A1 | CARNITINE DERIVATIVE, SALT THEREOF, EXTERNAL SKIN PREPARATION AND COSMETIC MATERIAL | CRAT, CUTA, SLC25A20 | KDM5A 1600/4885PHF8 717/4885KDM4C 1480/4885 |
| US-20090240070-A1 | WHITENING DERMATOLOGICAL PREPARATIONS | RBP1, TYR, TTPA | KDM5A 399/4885PHF8 448/4885KDM4C 1692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.